Exhausted T cell signature predicts immunotherapy response in ER-positive breast cancer.

MLA

Terranova-Barberio, Manuela, et al. “Exhausted T Cell Signature Predicts Immunotherapy Response in ER-Positive Breast Cancer.” Nature Communications, vol. 11, no. 1, July 2020, p. 3584. EBSCOhost, https://doi.org/10.1038/s41467-020-17414-y.

APA

Terranova-Barberio, M., Pawlowska, N., Dhawan, M., Moasser, M., Chien, A. J., Melisko, M. E., Rugo, H., Rahimi, R., Deal, T., Daud, A., Rosenblum, M. D., Thomas, S., & Munster, P. N. (2020). Exhausted T cell signature predicts immunotherapy response in ER-positive breast cancer. Nature Communications, 11(1), 3584. https://doi.org/10.1038/s41467-020-17414-y

Chicago

Terranova-Barberio, Manuela, Nela Pawlowska, Mallika Dhawan, Mark Moasser, Amy J Chien, Michelle E Melisko, Hope Rugo, et al. 2020. “Exhausted T Cell Signature Predicts Immunotherapy Response in ER-Positive Breast Cancer.” Nature Communications 11 (1): 3584. doi:10.1038/s41467-020-17414-y.